Publications 1997

Raffi F, Aboulker JP, Michelet C, Reliquet V, Pelloux H, Huart A, Poizot-Martin I, Morlat Ph, Dupas B, Mussini JM, Leport C, and the Bio-Toxo study group. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. AIDS 1997, 11 : 177-184.  Lien PubMed

Coulaud JP, Gougeon ML, Gomard E, Brun-Vézinet F, Lebon P, Aboulker JP, Bizzini B, Zagury D. A placebo controlled clinical phase I trial with combined anti-HIV1 and anti-alpha interferon immunization. AIDS 1997, 11 : 937-8. Lien PubMed

Pelloux H, Dupouy-Camet J, Derouin F, Aboulker JP, Raffi F, and the Bio-Toxo Study Group.A multicentre prospective study for the polymerase chain reaction detection of Toxoplasma gondii DNA in blood samples from 186 AIDS patients with suspected toxoplasmic encephalitis. AIDS 1997, vol 11 : 1888-9. Lien PubMed

Brun-Vezinet F, Boucher C, Loveday C, Descamps D, Fauveau V, Izopet J, Jeffries D, Kaye S, Krzysanowski C, Nunn A, Schuurman R, Seigneurin J-M, Tamalet C, Tedder R, Weber J, Weverling G-J, the National Virology Groups, and the Delta Virology Working Group and Coordinating Committee. HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The Lancet 1997, 350 : 983-990. Lien PubMed

Gérard L, Leport C, Flandre P, Hounou N, Salmon-Ceron D, Pépin JM, Mandet C, Brun-Vezinet F, Vildé JL. Cytomegalovirus (CMV) viremia and the CD4 + Lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 1997, 24 : 836-40.Lien PubMed